Tag: 2016

  • Julie Cooper – 2016 Parliamentary Question to the Department of Health

    Julie Cooper – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Julie Cooper on 2016-01-21.

    To ask the Secretary of State for Health, what measures and regulations are in place to ensure that clinical drug tests are low-risk and safe.

    George Freeman

    Clinical trials of medicinal products in the United Kingdom are strictly regulated by European Union and UK legislation in order to ensure that the studies achieve their scientific targets while safeguarding the trial participants. Before any trial of a new medicine is initiated in humans, the medicinal product will have undergone extensive non-clinical testing, both in the laboratory and in animals as appropriate. The organisation responsible for proposing the trial (the Sponsor) will submit a Clinical Trial Authorisation application that will be reviewed by both the Medicines and Healthcare products Regulatory Agency (MHRA) and a research ethics committee.

    The MHRA assesses the safety and scientific value of the trial. A team of assessors will review the pharmaceutical quality of the medicinal product, the supporting data from pre-clinical testing and the details of the trial design and methodology, along with all available clinical data. The research ethics committee will ensure that the participant has been fully informed of all the necessary information about the trial, including information on potential risks and side effects.

    All Phase I trials in healthy volunteers are assessed taking into account European guidelines on strategies to identify and mitigate risks for first in human (FIH) trials. In the UK, trials that are identified as being higher risk are referred by the MHRA to an Expert Advisory Group of the Commission on Human Medicines for advice.

    The MHRA has instituted a Phase I accreditation scheme for organisations conducting phase I trials, in particular for those conducting FIH trials. MHRA Inspectors will grant Phase I accreditation only to those research units that exceed the basic regulatory Good Clinical Practice standards by having additional procedures that include the highest standards for avoiding harm to trial subjects and for handling any medical emergencies.

  • Roger Godsiff – 2016 Parliamentary Question to the Department for Education

    Roger Godsiff – 2016 Parliamentary Question to the Department for Education

    The below Parliamentary question was asked by Roger Godsiff on 2016-02-19.

    To ask the Secretary of State for Education, what assessment she has made of the implications for her policies of the finding in the Chief Schools Adjudicator for England’s Annual Report, published in December 2015, that parents are often unable to understand the complicated admissions criteria employed by religiously selective schools.

    Nick Gibb

    Admission authorities for all state-funded schools, including schools with a religious character, are required to comply with the School Admissions Code. This includes a requirement that ‘parents should be able to look at a set of arrangements and understand easily how places for that school will be allocated’.

    We support the right of schools with a religious designation to prioritise children of their faith. The code requires such schools, as a minimum, to prioritise looked after and previously looked after children of their faith ahead of other children. We have no plans to change this requirement.

    The code can only be applied to bodies within the education sector. It cannot place requirements upon religious bodies. It does, however, require that when schools with a religious designation adopt admission criteria which prioritise children based on their faith, the schools must take account of religious activities as laid out by their religious authority.

    Compliance with the code is enforced by the Schools Adjudicator. Where an objection is made and the adjudicator finds that the arrangements are unclear, unfair, or that they otherwise fail to comply with the code, the admission authority is required by law to change the policy.

    The Government will shortly consult on a package of changes to the code which will both respond to the findings within the Chief Adjudicator’s Annual Reports and concerns raised by parents. That package will include measures to improve fairness and transparency.

  • Joan Ryan – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Joan Ryan – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Joan Ryan on 2016-03-07.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, pursuant to the Answer of 9 February 2016 to Question 25979, what financial assistance was provided to each of the (a) 10 Israeli non-governmental organisations (NGOs) receiving funding from the Conflict, Stability and Security Fund and (b) two NGOs receiving funds through the Bilateral Programme Budgets.

    Mr Tobias Ellwood

    The current funding for the ten NGO projects provided through the Conflict, Stability and Security Fund is: The Peres Centre for Peace – £0.046m; Injaz – Centre for Professional Arab Local Governance – £0.062m; Kids Creating Peace – £0.040m; Yesh Din – £0.2m; Gisha – £0.054m; Peace Now – £0.128m; Terrestrial Jerusalem – £0.052m; The International Peace and Cooperation Centre – £0.235m; Rabbis for Human Rights – £0.105m; and the Jerusalem Community Advocacy Network – £0.222m

    The current funding for the two NGO projects provided through the Bilateral Programme Budget is: Burj Al Luqluq Youth Centre – £0.019m; and Silwan Youth Centre – £0.005m

  • Paul Flynn – 2016 Parliamentary Question to the Prime Minister

    Paul Flynn – 2016 Parliamentary Question to the Prime Minister

    The below Parliamentary question was asked by Paul Flynn on 2016-04-13.

    To ask the Prime Minister, with reference to his Oral Statement of 11 April 2016, Official Report, column 26, on the Panama Papers, from which departmental budgets the Government plans to draw the resources to support the new cross-agency taskforce to analyse the information that has been made available in those papers.

    Mr David Cameron

    This is new money provided by the Treasury. It will be spent on bringing together some of the most sophisticated technology, experts and resources to tackle money laundering, tax evasion and wider forms of financial crime anywhere in the world.

  • Lord Empey – 2016 Parliamentary Question to the Department of Health

    Lord Empey – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Empey on 2016-05-19.

    To ask Her Majesty’s Government what estimate they have made of the mental and other health services that will be needed to assist the unaccompanied children who will be brought to the UK from refugee camps (1) in Europe, and (2) outside Europe.

    Lord Prior of Brampton

    The United Kingdom has been operating resettlement schemes for many years and we already have established and effective networks to accommodate and support resettled people. The increase in numbers will require an expansion of current networks and the impact on local communities and infrastructure will need to be managed carefully. That is why we are working with a wide range of partners to ensure that people are integrated sensitively into local communities and that we have the right support in place for unaccompanied refugee children who arrive in the UK from Europe whilst ensuring we fulfil our obligations to children who are already in the UK.

    The guidance, Statutory Guidance on Promoting the Health and Well-being of Looked After Children, sets out the health duties for local authorities, clinical commissioning groups (CCGs) and NHS England. The guidance sets out that local authorities and the National Health Service should take account any particular needs of the child, including if they are unaccompanied asylum seekers. This guidance is attached.

    Whilst there are a range of health care professionals, for example youth workers and teachers, who deliver interventions and support for children and young people with mental health conditions, clinical need should be determined by a specialist initial assessment in line with guidance produced by the National Institute for Health and Care Excellence.

    Local areas have published Local Transformation Plans that set out how mental health services will be delivered for their population. As part of their plans, local areas were asked to set out how they planned to meet the needs of more vulnerable groups, including unaccompanied refugee and asylum seeking children (UASC).

    NHS England ensures that all commissioners of health services have appropriate arrangements and resources in place to meet the physical, emotional and mental health needs of looked-after children, including UASC. They will work with local commissioners to raise awareness of the Resettlement Programme and highlight the additional numbers of children who will require their attention and support.

    Decisions about the resources needed to meet the mental health and other health needs of all children and young people, including UASC, are taken at a local level by CCGs. This may include decisions to recruit additional staff where necessary.

  • Lord Chidgey – 2016 Parliamentary Question to the Home Office

    Lord Chidgey – 2016 Parliamentary Question to the Home Office

    The below Parliamentary question was asked by Lord Chidgey on 2016-07-06.

    To ask Her Majesty’s Government what assessment they have made of the monitoring and oversight mechanisms in place in respect of the use of EU funds to ensure that the Khartoum Process complies with human rights norms.

    Lord Ahmad of Wimbledon

    The Government is continuing its Chairmanship of the Khartoum Process, and remains committed in its support for human rights. Our focus remains on the implementation of the actions agreed at last year’s EU-Africa Valletta Summit on migration.

    We are working with EU and international partners to ensure that EU funding underlying the Khartoum Process is properly monitored and overseen, including compliance with the EU Treaties which includes respect for human rights.

  • Keith Vaz – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Keith Vaz – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Keith Vaz on 2016-09-15.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, whether the Government plans to appoint a new Special Envoy to (a) Yemen and (b) Oman.

    Mr Tobias Ellwood

    There are no current plans to appoint a new special envoy.

  • Jeremy Lefroy – 2016 Parliamentary Question to the Department of Health

    Jeremy Lefroy – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jeremy Lefroy on 2016-01-21.

    To ask the Secretary of State for Health, what estimate he has made of the (a) cost to the economy and (b) number of deaths attributable to antimicrobial resistance in the last 12 months for which figures are available; whether he has made such estimates for future years; and if he will make a statement.

    Jane Ellison

    A broad estimate of the cost of antimicrobial resistance to the National Health Service is £180 million per annum.

    Antimicrobial resistance is a global problem. In the longer term, a forecast of the global economic costs and deaths attributable to antimicrobial resistance is available from the independent review on antimicrobial resistance led by Lord O’Neill of Gatley. His review estimates that drug-resistant infections could kill an extra 10 million people globally every year by 2050, and have a cumulative cost to the world of around $100 trillion in lost output.

    The United Kingdom is taking the lead in addressing antimicrobial resistance globally, investing £265 million in the Fleming Fund to strengthen surveillance of drug resistance and laboratory capacity in developing countries.

  • Jamie Reed – 2016 Parliamentary Question to the Department for Energy and Climate Change

    Jamie Reed – 2016 Parliamentary Question to the Department for Energy and Climate Change

    The below Parliamentary question was asked by Jamie Reed on 2016-02-19.

    To ask the Secretary of State for Energy and Climate Change, what assessment her Department has made of the potential effect of the Sellafield workforce reform initiative on workforce salary expenditure by Sellafield Ltd in (a) Copeland, (b) Allerdale, (c) Barrow-in-Furness and (d) Cumbria.

    Andrea Leadsom

    A new model, part of a suite of changes designed to increase efficiency in the business, is being put in place at Sellafield to increase efficiency in the business. The changes will have a positive impact on the Cumbrian economies, through encouraging supply chain companies to locate in the area as part of the Sellafield Change Programme.

    Details of the change programme are available at http://www.nda.gov.uk/contracts-and-competition/sellafield-model-change-programme/.

  • Jonathan Djanogly – 2016 Parliamentary Question to the Department of Health

    Jonathan Djanogly – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jonathan Djanogly on 2016-03-07.

    To ask the Secretary of State for Health, what assessment he has made of the reasons for the reductions in the number of people who use Stop Smoking Services in the last five years.

    Jane Ellison

    Although no formal assessment has been made of the reduction in the number of people accessing Local Stop Smoking Services in the last five years, Public Health England has been working with local areas, practitioners and experts in the field to better understand the reasons for the reduction in the number of people accessing services and consider how best to continue to help people stop smoking.